Etonogestrel And Ethinyl Estradiol Insert, Extended Release
Product Images NDC 0093-7679

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Etonogestrel And Ethinyl Estradiol (NDC 0093-7679). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Images 1)

Fig1 (Images 1)
The text provides information on the number of women with a blood clot out of 10,000 woman-years (WY) for different groups categorized as Non-CHC* User, CHCUser, Non-Pregnant, Pregnancy™*, and Postpartum (12 weeks only). It also shows the ranges of numbers for different categories, but there is not enough context to fully understand what these values represent.*
FDA Label Image

Final Carton (Images 10)

Final Carton (Images 10)
The text contains information on a vaginal ring that delivers a daily dose of 0.120mg of Etonogestrel and 0.015mg of Ethinyl Estradiol. It is recommended for preventing pregnancy, HIV infection, and sexually transmitted diseases. The text also includes some numbers and codes but no readable information to generate a useful description.*
FDA Label Image

Structural Formula (Images 2)

FDA Label Image

Fig2 (Images 3)

FDA Label Image

Pil_figure (Images 4)

Pil_figure (Images 4)
This appears to be a chart or infographic displaying different methods of birth control and their effectiveness rates. It shows that some methods, like sterilization, have a very low failure rate while others, like condoms and withdrawal, have a higher failure rate. It also lists various forms of contraception, including pills, injections, and devices like intrauterine devices and diaphragms. It appears to be intended to help people understand their options for preventing pregnancy.*
FDA Label Image

Fig1 (Images 5)

Fig1 (Images 5)
This appears to be a table or graph depicting data on blood clots in women, with different ranges of data for different categories such as CHC users and pregnant or postpartum women. The number 7 indicates the number of women with a blood clot out of 10,000 woman-years, but it is unclear which category this applies to. No further information or context is available.*
FDA Label Image

Fig-a,b,c (Images 6)

FDA Label Image

Fig D,e (Images 7)

FDA Label Image

Fig (f,g,h,i)

Fig (f,g,h,i)
This is a brief text that mentions the uterus, vagina, and a contraceptive device called Etonogestrel and Ethinyl Estradiol Vaginal Ring. There is also a reference to a figure labeled "H Figure" and the acronym TEED. No further information is provided.*
FDA Label Image

Fig-j (Images 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.